This Page Score: 0/40
Match the core biotechnological processes in List-I with their purpose or requirement in List-II:
| List-I (Core Process) | List-II (Purpose/Definition) |
| A. Genetic Material Isolation | I. Must be in pure form, free from other macromolecules |
| B. Bioprocess Engineering | II. Techniques to alter the chemistry of genetic material (DNA and RNA) |
| C. Genetic Engineering | III. Maintenance of sterile ambiance |
| D. Downstream Processing | IV. Separation and purification processes after biosynthetic stage |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the elements of the first recombinant DNA construction (List-I) with their properties or identity (List-II):
| List-I (Early Experiment Element) | List-II (Characteristic) |
| A. First recombinant DNA construction | I. Linked a gene encoding antibiotic resistance |
| B. Host for first RDNA replication | II. Salmonella typhimurium |
| C. Source of native plasmid for first RDNA | III. Escherichia coli |
| D. Characteristic of the linked gene | IV. Accomplished by Cohen and Boyer in 1972 |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the technique or substance (List-I) involved in the final stages of DNA isolation with its result (List-II):
| List-I (Technique/Substance) | List-II (Result/Use) |
| A. Chilled Ethanol | I. Removal of precipitated DNA threads |
| B. Spooling | II. Causes purified DNA to precipitate out of suspension |
| C. Precipitated DNA appearance | III. Used in constructing recombinant DNA |
| D. Purified DNA fragments | IV. Collection of fine threads in the suspension |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the term in List-I with its scientific definition or consequence in List-II:
| List-I (Term) | List-II (Definition/Example) |
| A. Recombinant DNA | I. Small, circular, autonomously replicating extra-chromosomal DNA |
| B. Plasmid | II. Combination of circular autonomously replicating DNA created in vitro |
| C. Cloning of gene | III. If expressed in a heterologous host, it is called this type of protein |
| D. Recombinant Protein | IV. Ability to multiply copies of an alien gene in a host (e.g., antibiotic resistance gene in E. coli) |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the challenge or limitation in List-I with its consequence or solution in List-II:
| List-I (Challenge/Limitation) | List-II (Solution/Consequence) |
| A. Cloning sites complexity | I. Leads to inclusion and multiplication of undesirable genes |
| B. Traditional Hybridisation | II. Need for very few, preferably single, recognition sites in the vector |
| C. Multiple recognition sites in vector | III. Will generate several fragments, complicating cloning |
| D. Genetic Engineering Techniques | IV. Allows isolation and introduction of only one or a set of desirable genes |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the phrases in List-I related to the EFB definition of biotechnology with the corresponding elements in List-II:
| List-I (EFB Definition Component) | List-II (Element) |
| A. Integration of | I. Products and services |
| B. Source materials | II. Natural science and organisms |
| C. Intermediate materials | III. Cells, parts thereof, and molecular analogues |
| D. Output goal | IV. Both traditional view and modern molecular biotechnology |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the genetic component in List-I with the related macromolecules found in the cell (List-II) that must be removed during DNA isolation:
| List-I (Genetic Material) | List-II (Other Macromolecule Released) |
| A. DNA | I. Proteins and Histones |
| B. Genes | II. RNA |
| C. Intertwined with DNA (in Eukaryotes) | III. Lipids |
| D. Cell membranes | IV. Polysaccharides |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the antibiotic selection steps (List-I) with the result or characteristic (List-II) when foreign DNA is inserted into the *tetR* gene of pBR322:
| List-I (Selection Step) | List-II (Outcome) |
| A. Plating on Ampicillin medium (pBR322) | I. Non-recombinants grow, recombinants die |
| B. Plating on Tetracycline medium (pBR322 with BamH I insertion) | II. Transformants grow, untransformed cells die |
| C. Non-recombinants on dual antibiotic medium | III. Used to identify the successful recombinants |
| D. Antibiotic inactivation process | IV. Grow on medium containing both antibiotics |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the production goal in List-I with the required system or condition in List-II, relating to Bioprocess Engineering:
| List-I (Goal) | List-II (Required System/Condition) |
| A. Higher yields of desired protein | I. Bioprocess engineering (sterile ambiance) |
| B. Large scale production | II. Continuous culture system (maintaining log/exponential phase) |
| C. Preventing contamination | III. Development of bioreactors (100-1000 litres) |
| D. Even mixing and $ ext{O}_2$ availability | IV. Stirrer/Agitator system in bioreactor |
[Biotechnology-Principles-and-Processes] [class-xii ]
Match the biotechnological product (List-I) with the type of cell (List-II) generally used for its manufacture or conversion in a bioreactor:
| List-I (Bioreactor Product) | List-II (Source Cell Type) |
| A. Antibiotics | I. Microbial cells |
| B. Vaccines | II. Microbial, Plant, Animal or Human cells |
| C. Individual enzymes | III. Used for manufacture (e.g., in bioprocess engineering) |
| D. General raw material conversion | IV. Microbial, Plant, Animal or Human cells |
[Biotechnology-Principles-and-Processes] [class-xii ]
This Page Score: 0/40